Correction to: ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Qian Chen, Xiao-Wei Zhou, Ai-Jun Zhang, Kang He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-021-01924-8 |
Similar Items
-
ACTN1 supports tumor growth by inhibiting Hippo signaling in hepatocellular carcinoma
by: Qian Chen, et al.
Published: (2021-01-01) -
Hepatic Hippo signaling inhibits development of hepatocellular carcinoma
by: Yuchen Liu, et al.
Published: (2020-10-01) -
Homoharringtonine Exerts Anti-tumor Effects in Hepatocellular Carcinoma Through Activation of the Hippo Pathway
by: Haina Wang, et al.
Published: (2021-02-01) -
A genetic variant in large tumor suppressor kinase 2 of Hippo signaling pathway contributes to prognosis of hepatocellular carcinoma
by: Shen LL, et al.
Published: (2016-04-01) -
MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma
by: Lei Guan, et al.
Published: (2019-10-01)